{"id":"neostigmine-with-glycopyrrolate","safety":{"commonSideEffects":[{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Muscle fasciculations"},{"rate":null,"effect":"Increased salivation (despite glycopyrrolate)"},{"rate":null,"effect":"Bronchospasm"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Neostigmine is a reversible acetylcholinesterase inhibitor that increases acetylcholine concentration at the neuromuscular junction and in the central nervous system. Glycopyrrolate is an anticholinergic agent added to this combination to prevent excessive muscarinic stimulation (salivation, bronchospasm, bradycardia) that would otherwise result from neostigmine monotherapy. Together, they enhance nicotinic effects while minimizing unwanted muscarinic effects.","oneSentence":"Neostigmine inhibits acetylcholinesterase to increase acetylcholine levels, while glycopyrrolate blocks muscarinic receptors to counteract cholinergic side effects.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:57:01.789Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Reversal of neuromuscular blockade after anesthesia"},{"name":"Myasthenia gravis"}]},"trialDetails":[{"nctId":"NCT05116930","phase":"PHASE2","title":"Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-11-19","conditions":"Post-Dural Puncture Headache","enrollment":18},{"nctId":"NCT06948409","phase":"","title":"NMBA Reversal and Postoperative Urinary Retention","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-06-08","conditions":"Neuromuscular Blocking Agents, Urinary Retention After Procedure, Urinary Retention Postoperative","enrollment":70000},{"nctId":"NCT06112353","phase":"PHASE4","title":"Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2024-04-17","conditions":"Intestinal Disease","enrollment":128},{"nctId":"NCT05985343","phase":"PHASE4","title":"The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction","status":"COMPLETED","sponsor":"Clayton Petro","startDate":"2024-01-15","conditions":"Hernia, Ventral, Ileus","enrollment":184},{"nctId":"NCT06398899","phase":"NA","title":"Sugammadex v.s. Neostigmine/Glycopyrrolate","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2024-05-01","conditions":"Head and Neck Surgery, Chronic Sinusitis, Chronic Otitis Media","enrollment":124},{"nctId":"NCT05887375","phase":"PHASE4","title":"Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"University of Missouri-Columbia","startDate":"2023-08-03","conditions":"Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative","enrollment":118},{"nctId":"NCT06228092","phase":"PHASE4","title":"Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients","status":"COMPLETED","sponsor":"Matias Vested","startDate":"2023-12-04","conditions":"Neuromuscular Blockade, Residual","enrollment":40},{"nctId":"NCT03909165","phase":"PHASE4","title":"Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-07-23","conditions":"Neuromuscular Blockade","enrollment":145},{"nctId":"NCT03111121","phase":"PHASE4","title":"Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy","status":"COMPLETED","sponsor":"West Virginia University","startDate":"2017-05-04","conditions":"Microlaryngoscopy, Rigid Bronchoscopy","enrollment":79},{"nctId":"NCT03116997","phase":"PHASE3","title":"Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2017-04-07","conditions":"Surgery","enrollment":201},{"nctId":"NCT03679611","phase":"PHASE4","title":"Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2019-01-14","conditions":"Obstructive Sleep Apnea","enrollment":120},{"nctId":"NCT05664633","phase":"PHASE1, PHASE2","title":"The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures","status":"WITHDRAWN","sponsor":"West Virginia University","startDate":"2023-08","conditions":"Postoperative Urinary Retention","enrollment":""},{"nctId":"NCT05545280","phase":"PHASE4","title":"Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2023-12-01","conditions":"Neuromuscular Blockade","enrollment":50},{"nctId":"NCT06735443","phase":"PHASE2, PHASE3","title":"Comparative Efficacy & Safety of Dexmedetomidine vs Tramadol in Paeds Hernioraphy. A Caudal Anaesthesia Approach","status":"COMPLETED","sponsor":"Sahiwal medical college sahiwal","startDate":"2021-03-06","conditions":"Hemodynamic Stability, Post Operative Pain, Inguinal Hernia Repair","enrollment":60},{"nctId":"NCT04546672","phase":"PHASE4","title":"Sugammadex To IMprove Bowel Function","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2021-03-16","conditions":"Bowel Dysfunction, Postoperative Complications, Neuromuscular Blockade","enrollment":120},{"nctId":"NCT05993390","phase":"NA","title":"Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2024-01-11","conditions":"Neuromuscular Blockade, Critical Illness, Neurologic Findings","enrollment":30},{"nctId":"NCT04606901","phase":"PHASE4","title":"Comparison of Time to Extubation Using Sugammadex or Neostigmine","status":"COMPLETED","sponsor":"Temple University","startDate":"2021-04-08","conditions":"Neuromuscular Blockade, Chronic Obstructive Pulmonary Disease","enrollment":58},{"nctId":"NCT05718934","phase":"PHASE4","title":"Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2022-11-08","conditions":"Neuromuscular Blockade","enrollment":144},{"nctId":"NCT02100280","phase":"PHASE4","title":"The Effect of Deep Block Versus Moderate Block on the Stress Response After Laparoscopic Gastrectomy","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-06-29","conditions":"Neuromuscular Blockade","enrollment":96},{"nctId":"NCT03939923","phase":"PHASE4","title":"Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery","status":"COMPLETED","sponsor":"West Virginia University","startDate":"2019-05-01","conditions":"Surgery, Coronary Artery Disease","enrollment":84},{"nctId":"NCT03904550","phase":"PHASE2","title":"Neuromuscular Blockade in Patients With Severe Renal Impairment","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-12-10","conditions":"Neuromuscular Blockade, Renal Impairment","enrollment":49},{"nctId":"NCT03513406","phase":"PHASE3","title":"Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-03-15","conditions":"Burns","enrollment":7},{"nctId":"NCT02825576","phase":"PHASE4","title":"Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine","status":"TERMINATED","sponsor":"Northern Sydney Anaesthesia Research Institute","startDate":"2018-12-03","conditions":"Pulmonary Complications","enrollment":30},{"nctId":"NCT05694234","phase":"","title":"Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2021-09-01","conditions":"Myasthenia Gravis","enrollment":265},{"nctId":"NCT03112993","phase":"PHASE4","title":"Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2017-05-30","conditions":"Spine Surgery","enrollment":40},{"nctId":"NCT01937247","phase":"PHASE2, PHASE3","title":"Redesigned Process in the Operating Room","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2018-05-18","conditions":"Non-operative Time, General Surgery, Above 18 Years of Age","enrollment":120},{"nctId":"NCT04873531","phase":"NA","title":"Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2021-05-10","conditions":"Thyroid Diseases, Surgical Injury, Nerve Monitoring","enrollment":44},{"nctId":"NCT03574337","phase":"PHASE4","title":"Residual Neuromuscular Blockade in Cardiac Surgery Patients","status":"WITHDRAWN","sponsor":"Henry Ford Health System","startDate":"2018-08-01","conditions":"Residual Neuromuscular Blockade","enrollment":""},{"nctId":"NCT04671030","phase":"PHASE1","title":"Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI","status":"COMPLETED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2018-01-15","conditions":"Spinal Cord Injuries, Constipation, Neurogenic Bowel","enrollment":6},{"nctId":"NCT03322657","phase":"PHASE4","title":"Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2017-11-14","conditions":"Neuromuscular Blockade, Anesthesia","enrollment":69},{"nctId":"NCT02574611","phase":"PHASE1","title":"Use of High Resolution Colonic Manometry in Studying Motility","status":"WITHDRAWN","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2015-10-13","conditions":"Gastrointestinal Dysfunction","enrollment":""},{"nctId":"NCT01422304","phase":"PHASE3","title":"Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-10-12","conditions":"Neuromuscular Blockade, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee","enrollment":1198},{"nctId":"NCT03351608","phase":"PHASE4","title":"Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-02-12","conditions":"Neuromuscular Blockade","enrollment":288},{"nctId":"NCT04332627","phase":"PHASE4","title":"Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2020-02-24","conditions":"Neuromuscular Blockade Reversal Agent, Sugammadex, Neostigmine","enrollment":77},{"nctId":"NCT04027959","phase":"NA","title":"Transdermal Iontophoresis of Vitamin B12 Under Three Different Skin Preparations","status":"COMPLETED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2017-10-05","conditions":"Macrocytic Anemia With Vitamin B12 Deficiency","enrollment":10},{"nctId":"NCT03346057","phase":"PHASE4","title":"Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-12-20","conditions":"Reversal of Neuromuscular Blockade","enrollment":344},{"nctId":"NCT03138967","phase":"PHASE4","title":"Investigation of Sugammadex in Outpatient Urological Procedures","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-09-18","conditions":"Malignant Neoplasms of Urinary Tract, Bladder Cancer","enrollment":54},{"nctId":"NCT03034577","phase":"PHASE4","title":"Deep Neuromuscular Block for Laparoscopic Surgery","status":"COMPLETED","sponsor":"University of Melbourne","startDate":"2017-06-16","conditions":"Laparoscopy, Anesthesia Recovery Period","enrollment":350},{"nctId":"NCT02861131","phase":"PHASE4","title":"The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2017-01-24","conditions":"Postoperative Complications, Neuromuscular Blockade","enrollment":200},{"nctId":"NCT03229486","phase":"PHASE4","title":"Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia","status":"COMPLETED","sponsor":"Pusan National University Yangsan Hospital","startDate":"2017-03-01","conditions":"Emergence Delirium","enrollment":40},{"nctId":"NCT00451100","phase":"PHASE3","title":"Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-11-10","conditions":"Anesthesia, General","enrollment":84},{"nctId":"NCT03432845","phase":"","title":"Rates and Severity of PONV for Neuromuscular Block Reversal in Patients Receiving Gastric Bypass Bariatric Surgery","status":"WITHDRAWN","sponsor":"WellSpan Health","startDate":"2018-06-01","conditions":"Bariatric Surgery Candidate","enrollment":""},{"nctId":"NCT03791801","phase":"NA","title":"The Use of Sugammadex in the Critically Ill","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2019-09-01","conditions":"Critical Illness","enrollment":50},{"nctId":"NCT03316963","phase":"EARLY_PHASE1","title":"Neostigmine For Snoring During DISE","status":"TERMINATED","sponsor":"Emory University","startDate":"2017-11-14","conditions":"Snoring","enrollment":1},{"nctId":"NCT03276026","phase":"PHASE4","title":"A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery","status":"TERMINATED","sponsor":"Virtua Health, Inc.","startDate":"2018-02-12","conditions":"Postoperative Nausea and Vomiting, Respiratory Conditions Due to Other External Agents","enrollment":68},{"nctId":"NCT00473694","phase":"PHASE3","title":"Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-11-28","conditions":"Anesthesia, General","enrollment":182},{"nctId":"NCT02580188","phase":"PHASE4","title":"The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2015-03-24","conditions":"Neuromuscular Blockade","enrollment":70},{"nctId":"NCT00451217","phase":"PHASE3","title":"Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-11-17","conditions":"Anesthesia, General","enrollment":198},{"nctId":"NCT02327923","phase":"PHASE4","title":"Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"B.P. Koirala Institute of Health Sciences","startDate":"2015-01","conditions":"Gall Stone Disease","enrollment":90},{"nctId":"NCT02375217","phase":"PHASE4","title":"\"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy\"","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2014-10","conditions":"Anesthesia Recovery","enrollment":56},{"nctId":"NCT01748643","phase":"PHASE4","title":"CURES: The Effect of Deep Curarisation and Reversal With Sugammadex on Surgical Conditions and Perioperative Morbidity","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2013-04","conditions":"Obesity, Laparoscopic Gastric Bypass Surgery, Surgical Conditions","enrollment":60},{"nctId":"NCT01050543","phase":"PHASE3","title":"Comparison of Sugammadex With Neostigmine as Reversal Agents for Rocuronium at Reappearance of T2 (Study P06101)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-02-01","conditions":"Neuromuscular Blockade","enrollment":128},{"nctId":"NCT01479764","phase":"PHASE3","title":"Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-12-02","conditions":"Surgical Procedures, Elective","enrollment":154},{"nctId":"NCT02370862","phase":"EARLY_PHASE1","title":"Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI","status":"COMPLETED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2013-02","conditions":"Spinal Cord Injury, Neurogenic Bowel","enrollment":28},{"nctId":"NCT01511627","phase":"NA","title":"Randomized Controlled Trial Comparing Postoperative Pain Following TAH With GA vs. Combined GA + SAB","status":"WITHDRAWN","sponsor":"University of Saskatchewan","startDate":"2012-01","conditions":"Hysterectomy","enrollment":""},{"nctId":"NCT02325648","phase":"","title":"The Intraoperative Physiologic Changes of Patients Under Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Cytoreductive Surgery; Prospective Observational Study","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2014-12","conditions":"Peritoneal Surface Malignancies","enrollment":22},{"nctId":"NCT02878512","phase":"PHASE4","title":"Segmental Epidural Anesthesia (SEA) V/S General Anesthesia for PCNL","status":"COMPLETED","sponsor":"Maharashtra University of Health Sciences","startDate":"2009-06","conditions":"Success Rate Under Segmental Epidural, Post Operative Pain","enrollment":60},{"nctId":"NCT02403063","phase":"PHASE4","title":"Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade","status":"COMPLETED","sponsor":"Onze Lieve Vrouw Hospital","startDate":"2015-09","conditions":"Respiratory Muscles, Electromyography","enrollment":18},{"nctId":"NCT01980069","phase":"NA","title":"A Double-blind, Randomized, Parallel Design Study to Compare the Effectiveness of Sugammadex Versus Neostigmine in Improving Surgical Condition in Subjects Undergoing Laryngeal Microsurgery","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2013-11","conditions":"General Anesthesia","enrollment":72},{"nctId":"NCT00675792","phase":"PHASE3","title":"Comparison of Sugammadex Administered at 1-2 Post Tetanic Counts (PTCs) or Better With Neostigmine Administered as Per Standard of Care to Reverse Rocuronium-Induced Neuromuscular Blockade in Adults Undergoing Elective Open Abdominal Procedure (19.4.334) (P05774)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-05","conditions":"Anesthesia","enrollment":100},{"nctId":"NCT00745095","phase":"PHASE4","title":"Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2009-03","conditions":"Spinal Cord Injury","enrollment":360},{"nctId":"NCT01199237","phase":"PHASE4","title":"Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-08","conditions":"Airway Reflexes, Protective, Recovery After Neuromuscular Block, Anesthetic Recovery","enrollment":107},{"nctId":"NCT02102542","phase":"","title":"Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia Service","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2012-07","conditions":"Hypersalivation, Prevention of Drooling, Bradycardia","enrollment":65},{"nctId":"NCT01338935","phase":"PHASE1","title":"Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2011-05","conditions":"Healthy","enrollment":136},{"nctId":"NCT00855283","phase":"PHASE2","title":"Intranasal Administration of a Prokinetic for Bowel Evacuation in Persons With SCI","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2012-09","conditions":"SCI","enrollment":20},{"nctId":"NCT01453530","phase":"PHASE4","title":"Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular Blockade","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2011-10","conditions":"Anesthesia Recovery Period","enrollment":30},{"nctId":"NCT01142648","phase":"PHASE4","title":"Sugammadex and Brain Waves","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2009-04","conditions":"Anaesthesia","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":231,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Neostigmine with glycopyrrolate","genericName":"Neostigmine with glycopyrrolate","companyName":"The Cleveland Clinic","companyId":"the-cleveland-clinic","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Neostigmine inhibits acetylcholinesterase to increase acetylcholine levels, while glycopyrrolate blocks muscarinic receptors to counteract cholinergic side effects. Used for Reversal of neuromuscular blockade after anesthesia, Myasthenia gravis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}